Home LiteratureArticle Details
PMID: 2892030 Published · ppublish English Clinical Trial Letter Randomized Controlled Trial

Bismuth/ofloxacin combination for duodenal ulcer.

Lancet (London, England) ·Vol. 2 ·No. 8573 ·1987-12-19 ·Pages 1467-8

Bayerdörffer E, Simon T, Bästlein C, Ottenjann R, Kasper G

Abstract

暂无摘要

MeSH Terms
Anti-Infective Agents/administration & dosage Bismuth Campylobacter Infections/drug therapy Clinical Trials as Topic Drug Therapy, Combination Duodenal Ulcer/drug therapy Humans Ofloxacin Organometallic Compounds/administration & dosage Oxazines/administration & dosage Random Allocation Salicylates/administration & dosage
Chemicals
Anti-Infective Agents Organometallic Compounds Oxazines Salicylates bismuth subsalicylate Ofloxacin Bismuth
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bayerdörffer E
Simon T
Bästlein C
Ottenjann R
Kasper G
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(87)91169-x
Published
1987-12-19
Pages
1467-8
Language
English
Region
England
NLM ID
2985213R
Subset
IM
External Links
PubMed source DOI: 10.1016/s0140-6736(87)91169-x View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2